A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)

GV Scagliotti; E.F. Smit; L Bosquee; M. O'Brien; A. Ardizzoni; P. Zatloukal; W. Eberhardt; M. Smid-Geirnaerdt; H.G. de Bruin; S. Dussenne; C Legrand; G. Giaccone

doi:10.1016/j.lungcan.2005.05.012

A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)

GV Scagliotti
, E.F. Smit
, L Bosquee
, M. O'Brien
, A. Ardizzoni
, P. Zatloukal
, W. Eberhardt
, M. Smid-Geirnaerdt
, H.G. de Bruin
, S. Dussenne
, C Legrand
, G. Giaccone

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	91-96
Journal	Lung Cancer
Volume	50
Issue number	1
DOIs	https://doi.org/10.1016/j.lungcan.2005.05.012
Publication status	Published - 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.lungcan.2005.05.012

Cite this

@article{ab3a7e9c8b954307aba9da974126f3e1,

title = "A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)",

author = "GV Scagliotti and E.F. Smit and L Bosquee and M. O'Brien and A. Ardizzoni and P. Zatloukal and W. Eberhardt and M. Smid-Geirnaerdt and \{de Bruin\}, H.G. and S. Dussenne and C Legrand and G. Giaccone",

year = "2005",

doi = "10.1016/j.lungcan.2005.05.012",

language = "English",

volume = "50",

pages = "91--96",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

TY - JOUR

T1 - A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)

AU - Scagliotti, GV

AU - Smit, E.F.

AU - Bosquee, L

AU - O'Brien, M.

AU - Ardizzoni, A.

AU - Zatloukal, P.

AU - Eberhardt, W.

AU - Smid-Geirnaerdt, M.

AU - de Bruin, H.G.

AU - Dussenne, S.

AU - Legrand, C

AU - Giaccone, G.

PY - 2005

Y1 - 2005

U2 - 10.1016/j.lungcan.2005.05.012

DO - 10.1016/j.lungcan.2005.05.012

M3 - Article

SN - 0169-5002

VL - 50

SP - 91

EP - 96

JO - Lung Cancer

JF - Lung Cancer

IS - 1

ER -